JANX(Janux Therapeutics, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-06-02 | Doyle Janeen Noel | Chief Corp. & Bus. Dev. Ofcr | 公开市场卖出 | 4,059 | $14.03 |
| 2026-05-11 | Dobek Maria | Vice President, Accounting | 公开市场卖出 | 2,038 | $14.17 |
| 2026-01-02 | McIver Zachariah | Chief Medical Officer | 公开市场卖出 | 2,714 | $13.73 |
| 2026-01-02 | Dobek Maria | Vice President, Accounting | 公开市场卖出 | 1,462 | $13.73 |
| 2026-01-02 | DiRaimondo Thomas | Chief Scientific Officer | 公开市场卖出 | 2,505 | $13.73 |
| 2026-01-02 | Winter Charles M. | Chief Technical Officer | 公开市场卖出 | 2,401 | $13.73 |
| 2026-01-02 | Meyer Andrew Hollman | Chief Business Officer | 公开市场卖出 | 1,879 | $13.73 |
| 2026-01-02 | Campbell David Alan | President and CEO | 公开市场卖出 | 8,072 | $13.73 |
| 2025-12-01 | Meyer Andrew Hollman | Chief Business Officer | 公开市场卖出 | 633 | $33.52 |
| 2025-12-01 | Meyer Andrew Hollman | Chief Business Officer | 公开市场卖出 | 2,700 | $32.85 |
| 2025-11-14 | Meyer Andrew Hollman | Chief Business Officer | 公开市场卖出 | 3,333 | $30.00 |
| 2025-10-28 | Meyer Andrew Hollman | Chief Business Officer | 公开市场卖出 | 16,665 | $30.06 |
| 2025-05-01 | Meyer Andrew Hollman | Chief Business Officer | 公开市场卖出 | 400 | $32.60 |
| 2025-05-01 | Meyer Andrew Hollman | Chief Business Officer | 公开市场卖出 | 2,933 | $31.95 |
| 2025-04-21 | Meyer Andrew Hollman | Chief Business Officer | 公开市场卖出 | 3,334 | $30.00 |
| 2025-03-07 | RA CAPITAL MANAGEMENT, L.P. | 董事、10% 股东 | 公开市场买入 | 110,206 | $31.02 |
| 2025-03-06 | RA CAPITAL MANAGEMENT, L.P. | 董事、10% 股东 | 公开市场买入 | 372,093 | $30.78 |
| 2025-03-05 | RA CAPITAL MANAGEMENT, L.P. | 董事、10% 股东 | 公开市场买入 | 37,455 | $31.30 |
| 2025-03-05 | RA CAPITAL MANAGEMENT, L.P. | 董事、10% 股东 | 公开市场买入 | 304,287 | $30.56 |
| 2025-03-03 | Meyer Andrew Hollman | Chief Business Officer | 公开市场卖出 | 901 | $32.85 |